Company intelligence / Profile preview

Core Medical Technology

Shenzhen, Guangdong, Chinacoretechmed.com ↗

Ownership: Private
Development stage: Commercial

Overview

Core Medical Technology has developed the Corheart 6, a miniaturized magnetic levitation implantable left ventricular assist system. The device has received approval for clinical trials from Chinese regulators and was successfully implanted in a pediatric patient, demonstrating its potential as the world’s lightest and smallest artificial heart. The company is advancing through late-stage development with significant venture funding to accelerate commercialization

Therapeutic areas: Cardiovascular
Modalities: Device (specifically, implantable left ventricular assist device)Magnetic levitation artificial heart technology
Industry: Implantable Medical Devices

Partnerships

Prosperity7 VenturesLoyal Valley CapitalLegend CapitalCoStone CapitalNew Alliance CapitalDelian Capital

Beyond the preview

Go deeper on Core Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Core Medical Technology.

Explore the full profile